Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00742508
What this trial is testing

A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure

Who this might be right for
Heart Failure, Congestive
GlaxoSmithKline 41
Early research (Phase 1)Study completedNCT02570074
What this trial is testing

PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults

Who this might be right for
Healthy Subjects
Vance Fowler, M.D. 19
Testing effectiveness (Phase 2)Study completedNCT03091920
What this trial is testing

Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension

Who this might be right for
Diabetes Mellitus, Type 2Hypertension
Cyclerion Therapeutics 26
Testing effectiveness (Phase 2)Looking for participantsNCT07223047
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+1 more
Bristol-Myers Squibb 252
Testing effectiveness (Phase 2)WithdrawnNCT01845623
What this trial is testing

Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture

Who this might be right for
Asthma
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT03101189
What this trial is testing

ACT-541468 in Healthy Japanese and Caucasian Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT06274489
What this trial is testing

Evaluate Setanaxib in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Calliditas Therapeutics AB 20
Early research (Phase 1)Study completedNCT03928379
What this trial is testing

LY3305677 in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT01323985
What this trial is testing

SAP Depleter Dose Escalation Study in Healthy Volunteers

Who this might be right for
Amyloidosis
GlaxoSmithKline 21
Early research (Phase 1)Study completedNCT03698513
What this trial is testing

Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 113
Early research (Phase 1)Study completedNCT06144710
What this trial is testing

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Hangzhou Sumgen Biotech Co., Ltd. 48
Early research (Phase 1)Not Yet RecruitingNCT07829406
What this trial is testing

See How Safe a New Medicine (NNC0642-1895) is in Healthy People

Who this might be right for
Healthy Volunteers
Novo Nordisk A/S 148
Testing effectiveness (Phase 2)Study completedNCT01435044
What this trial is testing

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 239
Testing effectiveness (Phase 2)UnknownNCT05465707
What this trial is testing

CM313 Injection in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Keymed Biosciences Co.Ltd 40
Early research (Phase 1)Study completedNCT05151653
What this trial is testing

Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin

Who this might be right for
Healthy
Boehringer Ingelheim 139
Testing effectiveness (Phase 2)Looking for participantsNCT06542237
What this trial is testing

Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males

Who this might be right for
Male Contraception
YourChoice Therapeutics, Inc. 88
Testing effectiveness (Phase 2)Study completedNCT01188772
What this trial is testing

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

Who this might be right for
Hepatitis C Virus
Gilead Sciences 147
Testing effectiveness (Phase 2)Study completedNCT00506792
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT00558909
What this trial is testing

4 Weeks Treatment of Type II Diabetic Patients With BI 44847

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 80
Early research (Phase 1)Study completedNCT06294301
What this trial is testing

Single and Multiple Doses of LP-005 in Healthy Adult Participants

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Longbio Pharma 68
Next Page